Zazove Associates’s IronNet, Inc. Redeemable Warrants, each whole warrant exercisable for shares of Common Stock at an exercise price of $11.50 per share IRNT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-204,574
Closed -$24K 167
2022
Q3
$24K Hold
204,574
﹤0.01% 156
2022
Q2
$76K Hold
204,574
0.01% 154
2022
Q1
$232K Buy
+204,574
New +$203K 0.02% 144
2021
Q3
$927K Buy
+203,574
New +$1.02M 0.08% 116

Other funds holding IRNT.WS

Zazove Associates's IRNT.WS Position: Q4 2022 in Review

Zazove Associates sold out of IronNet, Inc. Redeemable Warrants, each whole warrant exercisable for shares of Common Stock at an exercise price of $11.50 per share (IRNT.WS) in Q4 2022, closing a stake of 204,574 shares — an estimated $24K sold.

Zazove Associates first reported a position in IRNT.WS in Q3 2021 and held it in 4 quarters. The position peaked at $927K in Q3 2021. 10 funds tracked by Wall St. Rank hold IRNT.WS as of Q4 2022.

  • Zazove Associates reported no remaining IronNet, Inc. Redeemable Warrants, each whole warrant exercisable for shares of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Zazove Associates sold 204,574 IronNet, Inc. Redeemable Warrants, each whole warrant exercisable for shares of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $24K.
  • Zazove Associates first reported a position in IronNet, Inc. Redeemable Warrants, each whole warrant exercisable for shares of Common Stock at an exercise price of $11.50 per share in Q3 2021 and held it in 4 quarters.
  • Zazove Associates's IronNet, Inc. Redeemable Warrants, each whole warrant exercisable for shares of Common Stock at an exercise price of $11.50 per share position peaked at $927K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held IronNet, Inc. Redeemable Warrants, each whole warrant exercisable for shares of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Zazove Associates's 13F filing for Q4 2022, filed 31 Jan 2023.